Silver nanoparticles (AgNPs) are highly promising components for the development of innovative biomedical products. However, a critical issue remains the insufficient deep and quantitative understanding of their fundamental physicochemical properties. These properties essentially govern the bioactivity of silver nanoparticles and, consequently, the success of their biomedical applications. Current characterization methods do not fully capture the complex nature of AgNPs, leaving key questions unresolved, such as detailed surface properties, dynamic interactions in real biological environments, long-term changes, and the release of silver ions—all factors that influence the toxicity and performance of the nanoparticles. This gap in knowledge complicates the reproducibility of experiments, comparison of results, and proper evaluation of potential health risks associated with their use. While advanced techniques such as Atomic Force Microscopy (AFM), Inductively Coupled Plasma (ICP) spectroscopy, and X-ray Photoelectron Spectroscopy (XPS) further significantly our understanding, they still do not fully meet all the demands for understanding silver nanoparticles. Specifically, these methods face limitations in monitoring the dynamic and complex interactions of nanoparticles within real biological settings, especially physicochemical properties that are linked to toxicity and also the biological. Therefore, despite their invaluable role, these techniques represent only part of the solution for the thorough understanding and assessment of the biomedical performance of AgNPs, highlighting the need for continued research to ensure their safe and efficient biomedical utilization.
The design of new medical devices in biomedical engineering often necessitates the control of microbial load at the point of application, making antibacterial action valuable for numerous applications in the biomedical field. Nanotechnology products, such as silver nanoparticles (AgNPs), represent highly promising yet underexplored bioactive and antimicrobial agents that have attracted researchers’ interest for integration into medical devices. This study focuses on stable suspensions of silver nanoparticles, characterized by using a range of complementary physicochemical techniques as well as bacterial cell cultures, while also demonstrating controlled entrapment of the nanoparticles in collagen-based gels. The findings reveal that highly stable suspensions of negatively charged AgNPs (~6 nm in size) consistently exhibit broad-spectrum antimicrobial activity against both Gram-negative and Gram-positive bacteria, with minimum inhibitory concentration values of 10–20 ppm, whilst, importantly, close contact between the nanoparticles and bacterial cells turns out to be essential for their antibacterial action. Controlled entrapment of the nanoparticles in collagen-based gels enables regulation of nanoparticle release and their antimicrobial efficacy. This work highlights the promising prospects of silver nanoparticles in designing novel biomedical engineering products, while underscoring the need for a more comprehensive understanding of their biological activity to ensure optimal utilization.
Wound healing remains challenging, especially in chronic or infected lesions where standard dressings rarely restore full tissue integrity. Silver nanoparticles (AgNPs) have gained attention because they combine broad-spectrum antimicrobial activity with anti-inflammatory and pro-regenerative effects. Simultaneously, natural biopolymers like collagen and gelatin (key dermal extracellular matrix proteins) support tissue regeneration by promoting fibroblast infiltration, neovascularization, and granulation tissue formation. This review examines how integrating AgNPs with collagen creates combined beneficial effects in clinical practice that lead to multifunctional commercial dressings that exert infection control with advanced tissue repair and regulate silver release while maintaining a moist, hemostatic microenvironment. Preclinical studies support the potential of selected AgNP–collagen and AgNP–gelatin constructs to combine antimicrobial activity with matrix-supported repair, whereas clinical evidence is more extensive for the broader class of silver-containing dressings and some collagen/oxidized regenerated cellulose–silver products than for nanoparticle-decorated collagen systems specifically. Commercial and pipeline products, supported by clinical trials, validate the efficacy of AgNP–collagen dressings in the clinic. Key limitations that restrict their widespread use include limited commercialization potential based on small companies, microbial resistance and insufficient characterization of AgNPs, raising irreproducibility, toxicity and regulatory issues. Overall, nanostructured silver–collagen platforms can play a significant role in innovation towards next-generation wound care products.